Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
Emergent reversal of Vitamin K antagonists: Addressing all the factors
David T. Martin
, Cassie A. Barton
, Christopher Dodgion
, Martin Schreiber
Research output
:
Contribution to journal
›
Article
›
peer-review
16
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Emergent reversal of Vitamin K antagonists: Addressing all the factors'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Vitamin K Antagonists
100%
Prothrombin Complex Concentrate
100%
International Normalized Ratio
28%
Deep Vein Thrombosis
21%
Warfarin
14%
Warfarin Reversal
14%
Patient Demographics
7%
Retrospective Review
7%
Traumatic Injury
7%
Clinical Decision-making
7%
Acute Bleeding
7%
Coagulopathy
7%
Trauma Patients
7%
Traumatic Hemorrhage
7%
Reduced Mortality
7%
In-hospital Mortality
7%
Laboratory Data
7%
Injury Severity
7%
Activated Factor VII
7%
Kcentra
7%
Nursing and Health Professions
Antivitamin K
100%
Prothrombin Complex
100%
International Normalized Ratio
26%
Warfarin
26%
Deep Vein Thrombosis
20%
Blood Clotting Disorder
6%
Blood Clotting Factor 7
6%
Hospital Mortality
6%
Bleeding
6%
Supplementation
6%
Injury Severity
6%
Blood Clotting Factor 9 Complex
6%
Decision-Making
6%
Pharmacology, Toxicology and Pharmaceutical Science
Prothrombin Complex
100%
Antivitamin K
100%
Warfarin
26%
Deep Vein Thrombosis
20%
Bleeding
6%
Blood Clotting Disorder
6%
Hospital Mortality
6%
Blood Clotting Factor 7
6%
Injury Severity
6%
Blood Clotting Factor 9 Complex
6%
Neuroscience
Prothrombin Complex
100%
Vitamin K Antagonist
100%
Warfarin
26%
Deep Vein Thrombosis
20%
Decision-Making
6%
Factor VII
6%
Blood Clotting Factor 9 Complex
6%
Coagulopathy
6%